: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Fri, 06 Nov 2009 17:26:18 GMT

Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.[More...]

Bulls Back On Track?

Fri, 06 Nov 2009 16:21:18 GMT

Good morning. With chants of "Dow 10K… Dow 10K" once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.[More...]

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Fri, 06 Nov 2009 13:52:50 GMT

Ford's 2,215 page 2007 master contract with the UAW 1941 UAW-Ford contract[More...]

Your Kind of Day?

Thu, 05 Nov 2009 19:06:48 GMT

As a rule, I try not to read too terribly much into a "Fed Day" as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on "Fed Days." But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.[More...]

The Dollar-Proof Portfolio

Thu, 05 Nov 2009 17:31:14 GMT

Don't put off this important piece of the financial-planning process.[More...]

What Investors Should Look for In Today’s Fed Statement

Wed, 04 Nov 2009 13:04:24 GMT

In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).[More...]

Are Discount Brokers Shares Worth Owning?

Wed, 04 Nov 2009 01:28:03 GMT

The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&P gain 15%.[More...]

Technology Rises And Buying Facebook

Tue, 03 Nov 2009 16:54:11 GMT

Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%. Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.[More...]

Buffett Gets His Cheque Book Out

Tue, 03 Nov 2009 16:17:34 GMT

Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.[More...]

Five Ways To Ride The Commodities Bull

Tue, 03 Nov 2009 15:21:07 GMT

Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over. Don’t believe it.[More...]

Earnings Preview: Bristol-Myers 3Q earnings report

Wed, 21 Oct 2009 15:48:00 GMT

NEW YORK - Bristol-Myers Squibb Co., the world's No.
The following is a summary of key developments and analyst opinion related to the period.
OVERVIEW: Growing competition for its top drugs threatens revenue for the maker of blood thinner Plavix, the world's second-bestselling medication, and psychiatric drug Abilify.

: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Bulls Back On Track?

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Your Kind of Day?

The Dollar-Proof Portfolio

What Investors Should Look for In Today’s Fed Statement

Are Discount Brokers Shares Worth Owning?

Technology Rises And Buying Facebook

Buffett Gets His Cheque Book Out

Five Ways To Ride The Commodities Bull

Earnings Preview: Bristol-Myers 3Q earnings report

Chicago Tribune Gail MarksJarvis Column: Recession's End Doesn't Make Stock Picking Easy

Daily Mail, London, Market Report Column

Evening Standard, London, Market Report Column

UPI NewsTrack Business

Onglyza approved for Type 2 Diabetes

Astra 2Q profit up 6 pct as it cuts costs

Home Sales, Earnings Reports Ignite Markets

Dow tops 9,000 as home sales rise for 3rd month

Strong sales boost Bristol-Myers 2Q profit

Symyx Technologies Reports Third Quarter 2009 Financial Results

Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter

Mead Johnson Reports Solid Third Quarter Results; Narrows Full-Year 2009 Guidance to Top End of Range

Symyx Joins SAFE-BioPharma to Ensure Safe Security Standards for ELN Software; Pharmaceutical Industry Non-Profit Maintains Standards and Certification for Digital Signatures

Bristol-Myers Squibb Announces Dividend

Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.

Bristol-Myers Squibb Completes Initial Tender Offer for Medarex, Inc. With 87.7% of Shares Tendered; Announces Subsequent Offering Period

Symyx Announces Advances in Laboratory Information Analysis and Reporting

Bristol-Myers Squibb Extends Tender Offer for Medarex, Inc.

Morning Watch for Wednesday: Sunwin International Neutraceuticals - August 19, 2009

Form 4 MCBRIDE ANTHONY A For: Nov 01 (10K)

Form 4 Williams R Sanders For: Sep 30 (10K)

Form 4 WEST TOGO D JR For: Sep 30 (10K)

Form 4 GROBSTEIN MICHAEL For: Sep 30 (10K)

Form 4 HOOPER ANTHONY C For: Sep 21 (10K)

Form 4 SIGAL ELLIOT For: Sep 21 (10K)

Form 4 ANDREOTTI LAMBERTO For: Sep 21 (10K)

Form 4 Zito Robert T For: Aug 02 (10K)

Form 4 WEST TOGO D JR For: Jun 30 (10K)

Form 4 GROBSTEIN MICHAEL For: Jun 30 (10K)